Journal of Clinical Endocrinology & Metabolism, Vol 76, 769-776, Copyright © 1993 by Endocrine Society

ARTICLES

Cellular localization of membrane metalloendopeptidase (enkephalinase) in human endometrium during the ovarian cycle

JR Head, PC MacDonald and ML Casey
Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas 75235-9051.

Previously, we found that membrane metalloendopeptidase (MMEP; enkephalinase) is present in human endometrium where it may inactivate certain bioactive peptides such as endothelin. The specific activity of MMEP in endometrium is correlated positively with the level of plasma progesterone. In the present study, we determined the cellular distribution of MMEP immunoreactivity (IR) in samples of endometrium from 31 ovulatory women at different phases of the menstrual cycle and from 5 postmenopausal women. At all times, MMEP-IR was localized in the endometrial stromal cells and was absent from myometrium, epithelia, and vessels. The presence of the enzyme on the stromal cell plasma membrane was demonstrated by immunostaining of freshly isolated endometrial stromal cells. During the endometrial cycle, there were dramatic changes in MMEP-IR in the zona functionalis: In the proliferative phase when plasma progesterone levels were low, MMEP-IR was weak; but after ovulation, during the early and midsecretory phases, when progesterone levels were increasing or high, MMEP-IR was strong. During the late secretory phase, in the stromal areas that were decidualized, contiguous with spiral arterioles and beneath the surface epithelium, most of the MMEP-IR was lost, whereas MMEP in the other stromal areas remained strong. In the premenstrual phase, there was a more generalized decline in MMEP-IR in the stromal cells. MMEP-IR in the zona basalis was weak to moderate and was relatively unchanged during the ovarian cycle; the findings in postmenopausal tissues were similar to those of proliferative phase tissues. These results are consistent with the previous findings of increased MMEP mRNA, protein, and activity in endometrial tissue of midsecretory phase and in cultured endometrial stromal cells in response to progestin. Furthermore, in this study, we demonstrate that in the late secretory phase in decidualizing stroma, MMEP-IR is decreased considerably compared with midsecretory stromal cells. These changes in MMEP-IR are consistent with the possibility that endothelin, also produced in endometrium, is spared inactivation in the premenstrual phase and may act on the spiral arterioles. These findings are supportive of a role for MMEP in paracrine interactions affecting vascular homeostasis in the endometrium.

This article has been cited by other articles:

				K. Qian, H. Chen, Y. Wei, J. Hu, and G. Zhu Differentiation of endometrial stromal cells in vitro: down-regulation of suppression of the cell cycle inhibitor p57 by HOXA10? Mol. Hum. Reprod., April 1, 2005; 11(4): 245 - 251. [Abstract] [Full Text] [PDF]

				M. Edlund, E. Andersson, and G. Fried Progesterone withdrawal causes endothelin release from cultured human uterine microvascular endothelial cells Hum. Reprod., June 1, 2004; 19(6): 1272 - 1280. [Abstract] [Full Text] [PDF]

				H. Okada, T. Nakajima, M. Sanezumi, A. Ikuta, K. Yasuda, and H. Kanzaki Progesterone Enhances Interleukin-15 Production in Human Endometrial Stromal Cells in Vitro J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4765 - 4770. [Abstract] [Full Text]

				T. Morimoto, J. R. Head, P. C. MacDonald, and M. L. Casey Thrombospondin-1 Expression in Human Myometrium before and during Pregnancy, before and during Labor, and in Human Myometrial Cells in Culture Biol Reprod, October 1, 1998; 59(4): 862 - 870. [Abstract] [Full Text]

				N. Moghrabi, J. R. Head, and S. Andersson Cell Type-Specific Expression of 17{beta}-Hydroxysteroid Dehydrogenase Type 2 in Human Placenta and Fetal Liver J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3872 - 3878. [Abstract] [Full Text] [PDF]